AAAAAA
Results:
1-20
|
Results: 20
Authors:
MOOS M
SCHULZ R
MUREA S
HAAS R
Citation: M. Moos et al., DURATION OF T(14-18) PCR-NEGATIVITY AS PROGNOSTIC PARAMETER IN PATIENTS WITH FOLLICULAR NON-HODGKINS-LYMPHOMA UNDERGOING HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT, Bone marrow transplantation, 21, 1998, pp. 603-603
Authors:
HAAS R
SCHMID H
HAHN U
HOHAUS S
GOLDSCHMIDT H
MUREA S
KAUFMANN M
WANNENMACHER M
WALLWIENER D
BASTERT G
HUNSTEIN W
Citation: R. Haas et al., TANDEM HIGH-DOSE THERAPY WITH IFOSFAMIDE, EPIRUBICIN, CARBOPLATIN ANDPERIPHERAL-BLOOD STEM-CELL SUPPORT IS AN EFFECTIVE ADJUVANT TREATMENTFOR HIGH-RISK PRIMARY BREAST-CANCER, European journal of cancer, 33(3), 1997, pp. 372-378
Authors:
MUREA S
MOOS M
VOSO MT
HOHAUS S
GOLDSCHMIDT H
WANNENMACHER M
HAAS R
Citation: S. Murea et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION IN PATIENTS WITH INDOLENT NON-HODGKINS-LYMPHOMAS (NHL), Experimental hematology, 25(8), 1997, pp. 414-414
Authors:
HOHAUS S
PFORSICH M
MUREA S
ABDALLAH A
LIN YS
FUNK L
VOSO MT
KAUL S
SCHMID H
WALLWIENER D
HAAS R
Citation: S. Hohaus et al., IMMUNOMAGNETIC SELECTION OF CD34(-BLOOD STEM-CELLS FOR AUTOGRAFTING IN PATIENTS WITH BREAST-CANCER() PERIPHERAL), British Journal of Haematology, 97(4), 1997, pp. 881-888
Authors:
MOOS M
SCHULZ R
MUREA S
GOLDSCHMIDT H
HAAS R
Citation: M. Moos et al., MONITORING OF MINIMAL DISEASE IN PATIENTS WITH FOLLICULAR NON-HODGKINS-LYMPHOMA UNDERGOING HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT, Blood, 90(10), 1997, pp. 340-340
Authors:
HAAS R
MUREA S
Citation: R. Haas et S. Murea, THE ROLE OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN MOBILIZATION ANDTRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR AND STEM-CELLS (VOL 1,PG 249, 1995), Cytokines and molecular therapy, 2(2), 1996, pp. 136-136
Authors:
HAAS R
BRITTINGER G
MEUSERS P
MUREA S
GOLDSCHMIDT H
WANNENMACHER M
HUNSTEIN W
Citation: R. Haas et al., MYELOABLATIVE THERAPY WITH BLOOD STEM-CELL TRANSPLANTATION IS EFFECTIVE IN MANTLE CELL LYMPHOMA, Leukemia, 10(12), 1996, pp. 1975-1979
Authors:
MUREA S
GOLDSCHMIDT H
HAHN U
PFORSICH M
MOOS M
HAAS R
Citation: S. Murea et al., SUCCESSFUL COLLECTION AND TRANSPLANTATION OF PERIPHERAL-BLOOD STEM-CELLS IN CANCER-PATIENTS USING LARGE-VOLUME LEUKAPHERESES, Journal of clinical apheresis, 11(4), 1996, pp. 185-194
Authors:
HAAS R
MUREA S
KRONENWETT R
Citation: R. Haas et al., THE TELOMERE LENGTH OF BLOOD-DERIVED MONONUCLEAR-CELLS FROM CANCER-PATIENTS DURING G-CSF-ENHANCED MARROW RECOVERY CORRELATES WITH AGE BUT IS NOT RELATED TO THE CD34-CELL YIELD AND PREVIOUS CYTOTOXIC THERAPY( STEM), Experimental hematology, 24(9), 1996, pp. 105-105
Authors:
HAAS R
MOOS M
MOHLE R
DOHNER H
WITT B
GOLDSCHMIDT H
MUREA S
FLENTJE M
WANNENMACHER M
HUNSTEIN W
Citation: R. Haas et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN LOW-GRADE NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 17(2), 1996, pp. 149-155
Authors:
MOHLE R
MUREA S
PFORSICH M
WITT B
HAAS R
Citation: R. Mohle et al., ESTIMATION OF THE PROGENITOR-CELL YIELD IN A LEUKAPHERESIS PRODUCT BYPREVIOUS MEASUREMENT OF CD34-BLOOD( CELLS IN THE PERIPHERAL), Vox sanguinis, 71(2), 1996, pp. 90-96
Authors:
VOSO MT
MUREA S
GOLDSCHMIDT H
HOHAUS S
HAAS R
Citation: Mt. Voso et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION RESULTS IN A SIGNIFICANT REDUCTION OF THE HEMATOPOIETIC PROGENITOR-CELL COMPARTMENT, British Journal of Haematology, 94(4), 1996, pp. 759-766
Authors:
HAAS R
MUREA S
MOOS M
HOHAUS S
GOLDSCHMIDT H
HUNSTEIN W
Citation: R. Haas et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION IN LOW-GRADE NON-HODGKINS-LYMPHOMAS (NHL), Blood, 88(10), 1996, pp. 469-469
Authors:
HOHAUS S
FUNK L
BREHM M
ABDALLAH A
MUREA S
KAUL S
HAAS R
Citation: S. Hohaus et al., PERSISTENCE OF ISOLATED TUMOR-CELLS IN PATIENTS WITH BREAST-CANCER AFTER SEQUENTIAL HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSC), Blood, 88(10), 1996, pp. 501-501
Authors:
MOOS M
SCHULZ R
MUREA S
HAAS R
Citation: M. Moos et al., MINIMAL RESIDUAL DISEASE IN FOLLOW-UP SAMPLES OF PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA UNDERGOING HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT - IS THERE AN IMPACT ON THE CLINICAL OUTCOME, Blood, 88(10), 1996, pp. 881-881
Authors:
HAAS R
MUREA S
Citation: R. Haas et S. Murea, THE ROLE OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN MOBILIZATION ANDTRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR AND STEM-CELLS, Cytokines and molecular therapy, 1(4), 1995, pp. 249-270
Authors:
HAAS R
MUREA S
GOLDSCHMIDT H
DOHNER H
MOOS M
WITT B
EUGENHART R
WANNENMACHER M
HUNSTEIN W
Citation: R. Haas et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH NON-HODGKINS-LYMPHOMA, Stem cells, 13, 1995, pp. 28-35
Authors:
MOHLE R
MUREA S
KIRSCH M
HAAS R
Citation: R. Mohle et al., DIFFERENTIAL EXPRESSION OF L-SELECTIN, VLA-4, AND LFA-1 ON CD34(-MARROW AND PERIPHERAL-BLOOD DURING G-CSF-ENHANCED RECOVERY() PROGENITOR CELLS FROM BONE), Experimental hematology, 23(14), 1995, pp. 1535-1542
Authors:
FRUEHAUF S
HAAS R
CONRADT C
MUREA S
WITT B
MOHLE R
HUNSTEIN W
Citation: S. Fruehauf et al., PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) COUNTS DURING STEADY-STATE HEMATOPOIESIS ALLOW TO ESTIMATE THE YIELD OF MOBILIZED PBPC AFTER FILGRASTIM (R-METHUG-CSF)-SUPPORTED CYTOTOXIC CHEMOTHERAPY, Blood, 85(9), 1995, pp. 2619-2626
Authors:
KRAMER A
HAAS R
MUREA S
KIRSCH M
PANTEL K
RIETHMULLER G
BASTERT W
HUNSTEIN W
Citation: A. Kramer et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS AND DETECTION OF MINIMAL DISEASE IN PATIENTS WITH BREAST-CANCER, Blood, 84(10), 1994, pp. 10000108-10000108
Risultati:
1-20
|